The feedback from this community outreach event in 2012 was very favorable. We plan to do it again, updating the community on research and treatment developments in several areas of neurology. The tentative date is Saturday, Noveember 2, 2013, beginning in the morning, again on UB’s North Campus. Topics will include stroke, memory disorders, multiple sclerosis, neuroimaging, and neuromuscular disorders.
The University at Buffalo’s Pediatric Multiple Sclerosis (MS) Center of Excellence will share in a $2.5 million National Multiple Sclerosis Society grant announced July 1.
UB MED Collaborations
A New Image of Multiple Sclerosis: UB Neurologists reveal key role of thalamus in the disease.
by Ellen Goldbaum
Neurologists at UB and their international collaborators have found that measuring atrophy of the thalamus using routine magnetic resonance imaging can be an important tool in detecting, evaluating, and predicting the course of multiple sclerosis.
Read it here: Dr. Zivadinov page 26
Dr. Robert Zivadinov and Dr. Ralph Benedict present findings about the important role of the Thalamus in MSPosted: March 24, 2013
Multiple Sclerosis research: The thalamus moves into the spotlight; Atrophy of the thalamus is an important predictor of clinically definite MS, study shows
By: Ellen Goldbaum
BUFFALO, N.Y. – A growing body of research by multiple sclerosis (MS) investigators at the University at Buffalo and international partners is providing powerful new evidence that the brain’s gray matter reflects important changes in the disease that could allow clinicians to diagnose earlier and to better monitor and predict how the disease will progress.
Over the past three years, the UB researchers and their partners around the world, supported by an active fellowship program at UB’s Buffalo Neuroimaging Analysis Center (BNAC), have published journal papers and given presentations demonstrating that the thalamus region, in particular, is key to a host of issues involving MS.
“The thalamus is providing us with a new window on MS,” says Robert Zivadinov, MD, PhD, UB professor of neurology, BNAC director and leader of the research team. “In our recent studies, we have used large datasets to investigate the evolution of atrophy of the thalamus and its association with clinical impairment in MS, starting with the earliest stages of the disease. The location of the thalamus in the brain, its unique function and its vulnerability to changes wrought by the disease make the thalamus a critical barometer of the damage that MS causes to the brain.”
Zivadinov and UB professor of neurology Ralph Benedict discuss the new research in a video at (http://youtu.be/QhsaHeBjZrA).
At the annual meeting of the American Academy of Neurology today, Zivadinov will discuss a study he performed in collaboration with colleagues from Charles University in Prague. The study found that atrophy of the thalamus, determined with MRI, can help identify which patients with clinically isolated syndrome (CIS), a patient’s first episode of MS, are at risk for developing clinically definite MS. Such a tool would be immensely helpful to clinicians, Zivadinov notes.
Media Advisory: State Sen. Grisanti and UB researchers advocate state funding for NYS Multiple Sclerosis Registry and Consortium
WATCH THE SUPPORT:
BUFFALO, N.Y. — New York State Senator Mark Grisanti will join multiple sclerosis researchers at the University at Buffalo and patients to advocate for funding by New York State to maintain and expand the New York State MS Registry and the New York State MS Consortium, directed by Bianca Weinstock-Guttman, MD, UB professor of neurology.
When: 1 p.m., March 15, 2013
Where: UB’s Clinical and Translational Science Center, 5 floor, above the Gates Vascular Institute, 875 Ellicott Street, Buffalo
Why: MS Awareness Week runs from March 11 to 17. The incidence of MS in Western New York is twice the national average. The disease costs New York State between $1.5 and $2.3 billion each year. Support for the registry and consortium of 15 MS centers across the state will facilitate NYS research on MS, boost physician knowledge about the disease and improve the quality of life for the 30,000 New York State residents with MS.
Speakers will include:
· State Sen. Mark Grisanti, a member of the MS Legislative Alliance for the New York State Senate, and whose family has been affected by MS
· Bianca Weinstock-Guttman, MD, UB professor of neurology in the School of Medicine and Biomedical Sciences, and director of the NYS MS Registry
· Murali Ramanathan, PhD, UB professor of pharmaceutical sciences in the School of Pharmacy and Pharmaceutical Sciences and MS researcher
· An MS patient
Press arrangements: Ellen Goldbaum of UB University Communications at 645-4605 and 771-9255 onsite.
The ANNETTE FUNICELLO RESEARCH FUND FOR NEUROLOGICAL DISEASES is calling Mousketeer and Beach Party fans to support multiple sclerosis research by world-renowned MS researcher, Robert Zivadinov of the University at Buffalo.
Your gift will be matched up to $7,500 by the Annette Funicello Research Fund.
Your support will allow Dr. Zivadinov and his team at the Buffalo Neuroimaging Analysis Center to learn more about Pediatric Multiple Sclerosis.
To make a gift, go to: http://www.giving.buffalo.edu/funicello
For information about MS research at University at Buffalo by Dr. Zivadinov, go to: www.BNAC.net
For information about the Annette Funicello Research Fund for Neurological Diseases, go to: https://calfund.org/page.aspx?pid=638
If you want to distribute flyers for this excellent cause: Funicello Fund Flyer
Buffalo study offers hope to multiple sclerosis patients
Scientists in recent years have found a way to infuse stem cells into the brains of animals to repair damage to the central nervous system, offering some of the most encouraging news yet for multiple sclerosis patients.
Now, a key $12.1 million study soon will be under way in Buffalo and two other upstate medical centers that will for the first time begin to test the procedure in people.
The hope is that the stem cells will generate new myelin, the fatty substance that surrounds nerves like the insulation on a wire. Myelin is damaged in MS, leading to weak or lost signals between nerves. Eventually, the painful disease spreads in a slow, unpredictable path toward paralysis.
by: Henry Davis
Read about it: www.buffalonews.com
The state of New York has committed to fund the project through the stem cell fund.
Dr. Bianca Weinstock-Guttman, MD, co-principal investigator on the study, is Professor of Neurology, State University of New York at Buffalo, and Director of the Baird MS Center at The Jacobs Neurological Institute. She is also the Director of the Pediatric MS Center of the Jacobs Neurological Institute, one of six centers of excellence established by the National MS Society. In addition, she also serves as Executive Director of the New York State Multiple Sclerosis Consortium (NYSMSC).
The Stroke Division of the Univ. at Buffalo Department of Neurology played a key role in the recognition of Buffalo General Medical Center as a Top Performer in all areas of acute stroke management. The New York State Coverdell Acute Stroke Registry Program awarded Buffalo General Medical Center top status in median door to needle time for tPA therapy (<60 minutes), dysphagia screening, hyperlipidemia evaluation and management, and stroke education. The Stroke Division is directed by Dr. Robert Sawyer, Associate Professor and Vice Chair of Clinical Affairs for the Department of Neurology. His colleagues are Drs. Marilou Ching, Christopher Deline, Ashkan Mowla, and Peyman Shirani, all Assistant Professor of Neurology.
Gil I. Wolfe, MD, Irwin and Rosemary Smith Professor and Chairman of the Dept. of Neurology, is the recipient of the 2015 Doctor of the Year Award from the Myasthenia Gravis Foundation of America (MGFA). Dr. Wolfe has been a member of the MGFA’s Medical Scientific Advisory Board since 2001 and is its immediate past president. He has organized annual scientific sessions for the MGFA and was co-organizer of the last International Conference on MG and Related Disorders, held in New York City in 2012. With his colleague, Dr. Nick Silvestri in the Dept. of Neurology, he co-writes a regular column published in the MFGA Foundation Focus newsletter, “What’s Hot off the Press in Neuromuscular Junction Disorders?” to keep the MG community apprised of the latest developments in the field.
The UB Dept. of Neurology held its annual Michael E. Cohen, MD, Residents Research Day and Graduation Banquet on June 12, 2015. All graduating residents presented their research findings, while the PGY-3 level residents presented research plans. The Research Day was coordinated by Dr. Robert Zivadinov and his Buffalo Neuroimaging Analysis Center staff. Winners of the Outstanding Resident Presentation Awards for Research Day were Deeya Gaindh, MD and Karanbir Singh, MBBS, both PGY4s, and Haris Kamal, MD, PGY3. The Research Day program is available here: Research Day 2015 Program
At the Graduation Dinner banquet, Pooja Sofat, MBBS, PGY4 and co-chief resident, received the teaching award from the medical students. Nour Abdelhamid, MBChB, PGY4 and co-chief resident, received the Edward Fogan Annual Neurology Prize that recognizes excellence in clinical practice and compassionate care. Graduating residents were Drs. Nour Abdelhamid, Ghasan Ahmad, Deeya Gaindh, Naeem Mahfooz, Muhammad Masud, Karanbir Singh, and Pooja Sofat. Graduating neurophysiology fellows were Drs. Ahmad Abokhamis, Sunil Naik, and Katie Warren. Also graduating are neuroimaging fellow Dr. Javier Chapa and neurovascular fellow Luis Arangua. The incoming neurology chief residents for 2015-16 are Drs. Haris Kamal and Aurangzeb Memon. Eva Tamoga and Caleb Clark, administrative support staff for the training programs, played key roles in organizing the banquet.
Ralph Benedict, PhD, Professor of Neurology, has received the Chancellor’s Award for Excellence in Scholarship and Creative Activities for the 2014-15 academic year. The award recognizes SUNY faculty who demonstrate a record of sustained scholarship in their field. Dr. Benedict is internationally known for his research into the cognitive impairments seen in multiple sclerosis, memory disorders, and other neurological diseases. He has developed scales that are used worldwide to assess cognitive function in multiple sclerosis and is actively investigating strategies to help patients with the disorder remain productive both at home and the workplace. Dr. Benedict also directs the neuropsychology service for the Department of Neurology and is heavily involved with the training of graduate and postdoctoral students. Dr. Benedict was the only faculty member in the UB School of Medicine and Biomedical Sciences to receive the award this year. He was trained at Arizona State and Johns Hopkins universities and has been on the UB faculty since 1999.
The Univ. at Buffalo Dept. of Neurology Epilepsy Division, directed by Arie Weistock, MD, has again received Level 4 designation for its epilepsy center. Level 4 is the highest designation offered by the National Association of Epilepsy Centers and recognizes professional expertise and facilities that enable “the highest level of medical and surgical evaluation and treatment for patients with complex epilepsy.” The long-term monitoring unit for epilepsy evaluation is housed in Kaleida Health’s Women and Children’s Hospital in Buffalo and will expand to 12 beds in the new hospital being built on the downtown Buffalo Niagara Medical Campus.
Univ. at Buffalo Department of Neurology faculty have contributed to the recognition of Buffalo General Medical Center and Gates Vascular Institute as a Get With the Guidelines-Stroke Gold Plus Achievement Award Hospital. The award comes from the American Heart Association (AHA) which includes the American Stroke Association as a component body. Department of Neurology stroke faculty include Dr. Robert Sawyer, Stroke Center Director and department Vice Chair of Clinical Affairs, as well as Drs. Marilou Ching, Christopher Deline, Ashkan Mowla, and Peyman Shirani. Greater than 75% compliance is required on at least six stroke quality care measures to receive Gold Plus Achievement Award recognition. In addition, time to intravenous tPA therapy must be less than 60 minutes in 75% or more of treated cases. The stroke program has been recognized in the past by the AHA and has also achieved Comprehensive Stroke Center designation by DNV Healthcare, Inc.
The Univ. at Buffalo/SUNY Department of Neurology presented over 35 papers at the American Academy of Neurology (AAN) Annual Meeting held April 18-25, 2015 in Washington, DC. Topics covered included Alzheimer disease, epilepsy, multiple sclerosis and related syndromes, neuromuscular disease, neuro-ophthalmology, quality improvement, and stroke. Department faculty listed as first, senior or co-authors on the abstracts included Drs. Benedict, Ching, Dwyer, Fine, Hojnacki, Kolb, Mowla, Ramanathan, Silvestri, Szigeti, Teter, Weinstock-Guttman, Wolfe, and Zivadinov. Neurology housestaff included Drs. Abdelhamid, Abdelrazek, Ahmad, Fiddler, Gaindh, Kamal, Masud, Singh, and Sofat. Numerous research staff were also listed as authors including Katelyn Kavak and Kara Patrick. The 2015 AAN meeting broke the prior attendance record.